Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients

Clinical Transplantation

Volumn 24, Issue 6, 2010, Pages 778-783

  Luan, Fu L ^a,b   Langewisch, Eric ^a   Ojo, Akinlolu ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Kidney transplant; Metabolic syndrome; New onset diabetes

Indexed keywords

GLUCOSE; URIC ACID;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE FREE SURVIVAL; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULSE PRESSURE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; URIC ACID BLOOD LEVEL; WEIGHT GAIN;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 78649933033     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01194.x     Document Type: Article

References (25)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988: 37: 1595.
2. Porrini E, Delgado P, Bigo C et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis 2006: 48: 134-42.
3. Hjelmesaeth J, Hartmann A, Midtvedt K et al. Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant 2001: 16: 1047-52.
4. Kuypers DR, Claes K, Bammens B, Evenepoel P, Vanrenterghem Y. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM). Nephrol Dial Transplant 2008: 23: 2033-42.
5. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003: 3: 178-85.
6. Hjelmesaeth J, Hartmann A, Leivestad T et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006: 69: 588-95.
7. Cosio FG, Kudva Y, Van Der Velde M et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005: 67: 2415-21.
8. Roland M, Gatault P, Doute C et al. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation. Transpl Int 2008: 21: 523.
9. Genuth S, Alberti KG, Bennett P et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003: 26: 3160.
10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998: 15: 539.
11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006: 29(Suppl 1):S43.
12. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002:106: 3143.
13. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003: 52: 2160.
14. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U.S. adults. Obes Res 2003: 11: 1223.
15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002: 287: 356.
16. McNeill AM, Rosamond WD, Girman CJ et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005: 28: 385.
17. Espinola-Klein C, Rupprecht HJ, Bickel C et al. Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. Am J Cardiol 2007: 99: 1623.
18. Adeseun GA, Rivera ME, Thota S, Joffe M, Rosas SE. Metabolic syndrome and coronary artery calcification in renal transplant recipients. Transplantation 2008: 86: 728.
19. De Vries AP, Bakker SJ, Van Son WJ et al. Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant 2004: 4: 1675.
20. Kishikawa H, Nishimura K, Kato T et al. Prevalence of the metabolic syndrome in kidney transplantation. Transplant Proc 2009: 41: 181.
21. Rike AH, Mogilishetty G, Alloway RR et al. Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids. Clin Transplant 2008: 22: 229.
22. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000: 283: 2404.
23. Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology 2009: 114: 300.
24. Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998: 32: 560.
25. Domanski M, Norman J, Wolz M, Mitchell G, Pfeffer M. Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension 2001: 38: 793.